125 related articles for article (PubMed ID: 38563394)
1. Light-inducible nanodrug-mediated photodynamic and anti-apoptotic synergy for enhanced immunotherapy in triple-negative breast cancer.
Huang J; Liu X; Lin M; Xiao Z; Shuai X
Biomater Sci; 2024 May; 12(10):2639-2647. PubMed ID: 38563394
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of photodynamic therapy and chemotherapy: Activating the intrinsic/extrinsic apoptotic pathway of anoikis for triple-negative breast cancer treatment.
Zhang T; Wang X; Wang D; Lei M; Hu Y; Chen Z; Li Y; Luo Y; Zhang L; Zhu Y
Biomater Adv; 2024 Jun; 160():213859. PubMed ID: 38642515
[TBL] [Abstract][Full Text] [Related]
3. Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment.
Huang Y; Wu S; Li J; He C; Cheng Y; Li N; Wang Y; Wu Y; Zhang J
Int J Nanomedicine; 2024; 19():3737-3751. PubMed ID: 38699684
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.
Valcourt DM; Dang MN; Scully MA; Day ES
ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466
[TBL] [Abstract][Full Text] [Related]
5. Nanodrug Inducing Autophagy Inhibition and Mitochondria Dysfunction for Potentiating Tumor Photo-Immunotherapy.
Xiao H; Li X; Li B; Yang S; Qin J; Han S; Ren J; Shuai X
Small; 2023 Jul; 19(30):e2300280. PubMed ID: 37060227
[TBL] [Abstract][Full Text] [Related]
6. MnO
Zhang L; Yang R; Yu H; Xu Z; Kang Y; Cui H; Xue P
J Mater Chem B; 2021 May; 9(17):3677-3688. PubMed ID: 33949613
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporally-controlled hydrophobic drug delivery via photosensitizer-driven assembly-disassembly for enhanced triple-negative breast cancer treatment.
Kong F; He P; Jiang J; Zhu W; Lei Q
J Control Release; 2024 May; 369():53-62. PubMed ID: 38513728
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
9. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy.
Liu H; Hu Y; Sun Y; Wan C; Zhang Z; Dai X; Lin Z; He Q; Yang Z; Huang P; Xiong Y; Cao J; Chen X; Chen Q; Lovell JF; Xu Z; Jin H; Yang K
ACS Nano; 2019 Nov; 13(11):12638-12652. PubMed ID: 31625721
[TBL] [Abstract][Full Text] [Related]
11. Novel Carrier-Free Nanodrug Enhances Photodynamic Effects by Blocking the Autophagy Pathway and Synergistically Triggers Immunogenic Cell Death for the Efficient Treatment of Breast Cancer.
Xie L; Wang L; Li L; Liu C; Guo L; Liao Y; Zhou S; Wu W; Duo Y; Shi L; Yuan M
ACS Appl Mater Interfaces; 2024 Feb; 16(5):5683-5695. PubMed ID: 38261396
[TBL] [Abstract][Full Text] [Related]
12. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
13. Dual-Responsive and ROS-Augmented Nanoplatform for Chemo/Photodynamic/Chemodynamic Combination Therapy of Triple Negative Breast Cancer.
Chen M; Yang J; Zhou L; Hu X; Wang C; Chai K; Li R; Feng L; Sun Y; Dong C; Shi S
ACS Appl Mater Interfaces; 2022 Jan; 14(1):57-68. PubMed ID: 34935343
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Lin X; Mao D; Bai R
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs-Targeting Immunotherapy of Colon Cancer.
Ding D; Zhong H; Liang R; Lan T; Zhu X; Huang S; Wang Y; Shao J; Shuai X; Wei B
Adv Sci (Weinh); 2021 Jul; 8(14):e2100712. PubMed ID: 34021727
[TBL] [Abstract][Full Text] [Related]
16. Codelivery of anti-CD47 antibody and chlorin e6 using a dual pH-sensitive nanodrug for photodynamic immunotherapy of osteosarcoma.
Xiao J; Xiao H; Cai Y; Liao J; Liu J; Yao L; Li S
Oncol Res; 2024; 32(4):691-702. PubMed ID: 38560565
[TBL] [Abstract][Full Text] [Related]
17. A dual-sensitive nanoparticle-mediated deepening synergistic therapy strategy involving DNA damage and ICD stimuli to treat triple-negative breast cancer.
Liu S; Kong X; Fang Y; He Z; Wu H; Ji J; Yang X; Ye L; Zhai G
Biomater Sci; 2023 Sep; 11(18):6325-6341. PubMed ID: 37555273
[TBL] [Abstract][Full Text] [Related]
18. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy.
Hu C; Zhuang W; Yu T; Chen L; Liang Z; Li G; Wang Y
J Mater Chem B; 2020 Jun; 8(24):5267-5279. PubMed ID: 32441291
[TBL] [Abstract][Full Text] [Related]
19. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
[TBL] [Abstract][Full Text] [Related]
20. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
Yao D; Wang Y; Bian K; Zhang B; Wang D
Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
